ABSTRACT
The goal of the present research was to study the types of nutritional behavior disturbances in overweight patients with the pathology biliary tract. 132 patients with chronic noncalculous cholecystitis aged from 18 to 35 were examined. The comprehensive clinical examination was conducted and types of eating behavior disturbances with the help DEBQ test (Dutch Eating Behavior Questionnaire) were examined. It was discovered that disturbances of eating behavior are observed in 82,9 percent of normal weight patients, in 100 percent of overweight and in 93,3 percent of patients with obesity. Restraint and emotional eating are more often observed in obesity. External eating is more often observed in overweight and normal weight persons than that emotional eating. Rational eating is rarely observed in all groups of examined persons.
Subject(s)
Acalculous Cholecystitis/psychology , Feeding Behavior/psychology , Overweight/psychology , Acalculous Cholecystitis/complications , Acalculous Cholecystitis/epidemiology , Adolescent , Adult , Bashkiria , Body Mass Index , Case-Control Studies , Chronic Disease , Humans , Obesity/complications , Obesity/epidemiology , Obesity/psychology , Overweight/complications , Overweight/epidemiology , Young AdultABSTRACT
The therapeutic efficiency of ursosan in 64 overweight patients with chronic noncalculous cholecystitis and dysfunction of biliary tract was evaluated. Including of ursosan in the complex therapy of patients with chronic noncalculous cholecystitis enhances the efficiency of therapy, causes the positive changes in clinical symptoms and indicators of the biliary tract function, diminishes the lithogenic properties of bile, normalize the food behavior.
Subject(s)
Biliary Tract Diseases/therapy , Caloric Restriction , Cholagogues and Choleretics/therapeutic use , Obesity/therapy , Ursodeoxycholic Acid/therapeutic use , Adolescent , Adult , Biliary Tract Diseases/complications , Biliary Tract Diseases/diagnosis , Biliary Tract Diseases/psychology , Body Weight/drug effects , Cholagogues and Choleretics/administration & dosage , Combined Modality Therapy , Feeding Behavior , Humans , Obesity/complications , Obesity/diagnosis , Obesity/psychology , Surveys and Questionnaires , Treatment Outcome , Ursodeoxycholic Acid/administration & dosage , Young AdultABSTRACT
The therapeutic efficacy of duspatalin was evaluated in 72 patients with chronic cholecystitis and dyskinesia of the biliary tract (BT). Supplementation of duspatalin to the combined therapy in the patients with chronic cholecystitis shown to exert a pronounced therapeutic effect. This caused positive changes in clinical symptoms and BT function and quality of life, diminished the lithogenic properties of bile.
Subject(s)
Acalculous Cholecystitis/drug therapy , Parasympatholytics/therapeutic use , Phenethylamines/therapeutic use , Acalculous Cholecystitis/diagnosis , Acalculous Cholecystitis/psychology , Adolescent , Adult , Attitude to Health , Chronic Disease , Humans , Parasympatholytics/administration & dosage , Phenethylamines/administration & dosage , Quality of Life , Treatment Outcome , Young AdultABSTRACT
The therapeutic efficacy of duspatalin was evaluated in 69 patients with chronic cholecystitis and dyskinesia of the biliary tract (BT). Supplementation of duspatalin to the combined therapy in the patients with chronic cholecystitis shown to exert a pronounced therapeutic effect. This caused positive changes in clinical symptoms and BT function and quality of life, diminished the lithogenic properties of bile.
Subject(s)
Acalculous Cholecystitis/drug therapy , Parasympatholytics/therapeutic use , Phenethylamines/therapeutic use , Adult , Chronic Disease , Drug Therapy, Combination , Humans , Parasympatholytics/administration & dosage , Phenethylamines/administration & dosage , Quality of Life , Treatment OutcomeABSTRACT
The purpose of the study was to evaluate efficacy of poliphepan and hepabene as components of complex therapy in patients with chronic cholecystitis (CC). The subjects were 33 CC patients with biliary tract (BT) dyskinesia and biliar sludge. Application of the drugs led to significant improvement of clinical symptoms and the parameters of BT functional condition, as well as to decrease of bile lithogenicity and improvement of life quality.
